|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Aegis Capital on 2021-02-03. The analyst firm set a price target for 7.00 expecting KTRA to rise to within 12 months (a possible 426.32% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $1.33 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kintara Therapeutics.
There is no upcoming split for Kintara Therapeutics.